Vijaya Vaikari

Materials ScienceMedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Anti-FLT3 nanoparticles for acute myeloid leukemia: Preclinical pharmacology and pharmacokinetics”.

Anti-FLT3 nanoparticles for acute myeloid leukemia: Preclinical pharmacology and pharmacokinetics

Journal of Controlled Release(2020)10.1016/j.jconrel.2020.05.021

N/A

0DataRank · unranked

27 citations

Vijaya Vaikari, Albert T. Lam, Yong Zhang, J. Andrew MacKay, Houda Alachkar +1 more

Anti-CD99 scFv-ELP nanoworms for the treatment of acute myeloid leukemia

Nanomedicine Nanotechnology Biology and Medicine(2020)10.1016/j.nano.2020.102236

N/A

0DataRank · unranked

25 citations

Min-Cheol Park, Lena Keossayan, J. Andrew MacKay, Houda Alachkar, Vijaya Vaikari

CD99 in malignant hematopoiesis

Experimental Hematology(2021)10.1016/j.exphem.2021.12.363

N/A

0DataRank · unranked

14 citations

Vijaya Vaikari, Houda Alachkar, Atham Ali